Cancer and blood-related disorders remain a significant global health concern. According to data referenced by the World Health Organization, cancer is among the leading causes of morbidity and mortality worldwide, while hematologic conditions such as anemia, clotting disorders, leukemias, and lymphomas continue to require long-term, specialized care. As populations age and diagnostic capabilities improve, the demand for hematology-oncology services has steadily increased across Europe, including Central and Eastern European countries.
Poland has developed a structured and regulated healthcare system that supports both hematology and oncology services within academic, tertiary, and multispecialty hospitals. Hematologists-oncologists in Poland are trained through formal medical education, followed by specialist residencies and board certification aligned with European Union medical standards. Many clinicians participate in multidisciplinary tumor boards and adhere to internationally recognized clinical guidelines, including those referenced by European and global oncology societies. This structured approach supports evidence-based diagnosis, treatment planning, and long-term disease monitoring.
From an international patient perspective, Poland is often considered due to its modern hospital infrastructure, availability of advanced diagnostics, and comparatively moderate healthcare costs when evaluated against Western Europe. Care is typically delivered in an organized manner, with attention to patient safety, informed consent, and documentation. Psychological support services, including counseling and patient education, are increasingly integrated into oncology care pathways, recognizing the emotional and social impact of cancer and chronic blood disorders.
Overall, hematology-oncology care in Poland reflects a balance between clinical rigor, accessibility, and adherence to established medical standards. For patients exploring treatment abroad, understanding the scope, limitations, and regulatory framework of care is an important first step before making medical decisions.
Prof. Krzysztof Warzocha, MD
Specialization: Hematology and oncology
Years of Experience: Over 30 years
Prof. Warzocha has extensive clinical experience in the diagnosis and management of lymphomas, leukemias, and other hematologic malignancies. His work emphasizes evidence-based treatment protocols and participation in international clinical research. He has been associated with the National Institute of Oncology in Warsaw, where care is delivered within a multidisciplinary academic setting.
Dr. Joanna Góra-Tybor, MD
Specialization: Hematology-oncology
Years of Experience: Over 25 years
Dr. Góra-Tybor focuses on hematologic cancers and complex blood disorders, with clinical involvement in both inpatient and outpatient care. She practices at the Medical University of Łódź, where treatment planning follows European clinical guidelines and structured follow-up models.
Prof. Sebastian Giebel, MD
Specialization: Hematology and stem cell transplantation
Years of Experience: Over 20 years
Prof. Giebel’s clinical work includes hematologic malignancies and bone marrow transplantation. He is affiliated with the Maria Skłodowska-Curie National Research Institute of Oncology in Gliwice, where advanced therapies are delivered within regulated transplant programs.
Dr. Ewa Lech-Marańda, MD
Specialization: Hematology
Years of Experience: Over 25 years
Dr. Lech-Marańda is involved in the management of leukemias and bone marrow disorders, with a focus on standardized diagnostic pathways. She works at the Institute of Hematology and Transfusion Medicine in Warsaw, a national referral center for blood diseases.
Prof. Wiesław Jędrzejczak, MD
Specialization: Hematology-oncology and transplantation
Years of Experience: Over 35 years
Prof. Jędrzejczak has long-standing experience in hematologic oncology and stem cell transplantation. His clinical and academic work has been associated with the Medical University of Warsaw, where patient care is supported by multidisciplinary hospital teams.
Dr. Agnieszka Górska, MD
Specialization: Hematology
Years of Experience: Over 15 years
Dr. Górska’s clinical focus includes plasma cell disorders such as multiple myeloma. She practices within a university-affiliated hospital environment, participating in coordinated care pathways and long-term patient monitoring.
Prof. Tadeusz Robak, MD
Specialization: Hematology-oncology
Years of Experience: Over 30 years
Prof. Robak has contributed to clinical research and treatment of chronic leukemias and lymphoproliferative disorders. He has been associated with academic hospitals in Łódź, where care is delivered according to established European standards.
Doctor listings are provided for informational purposes only and do not represent rankings or endorsements.
| Consultation Type | Estimated Cost |
| Hematologists-Oncologists consultation | $250–$350 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing to seek specialist care outside your home country can feel complex and requires thoughtful consideration. Many patients explore international options to better understand available expertise, healthcare systems, and access pathways. Poland is one of several countries that international patients review when evaluating hematology-oncology care abroad.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
For foreign patients, it is important to plan for practical considerations alongside medical decisions. Visa or entry requirements may vary by nationality and length of stay. Depending on the condition and treatment plan, a postoperative or post-treatment stay of at least 7–14 days may be recommended by the treating team. While major cities often provide English-language support, language barriers may still exist outside large centers. Planning follow-up care in your home country is essential, as long-term monitoring and continuity of care play a key role in hematology-oncology outcomes.
Patients considering hematologists-oncologists care in Poland may share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and assistance in organizing communication with appropriate medical facilities.
Do I need a medical visa to consult hematologists-oncologists in Poland?
Visa requirements depend on your nationality and length of stay. Many patients from certain regions can enter Poland under short-term Schengen visa rules, while others may need a medical or visitor visa. It is important to check current embassy guidance and confirm documentation requirements before travel.
Will English be spoken during my medical consultation in Poland?
In many large hospitals and academic centers, physicians and international patient departments communicate in English. Some facilities also offer professional medical interpreters. Outside major cities, English availability may be more limited, so confirming language support in advance is recommended.
Can I have an online consultation with a hematologist-oncologist before traveling?
Yes, online consultations are often possible for initial case review. Through Best Clinic Abroad, you can arrange remote consultations with suitable specialists, allowing your medical records to be reviewed and helping you understand whether an in-person visit is appropriate before making travel plans.
How long should I plan to stay in Poland for hematology-oncology care?
The length of stay depends on your diagnosis, treatment plan, and whether procedures or ongoing therapies are involved. Some consultations may require only a short visit, while others may involve extended stays. Your treating team can guide once your clinical situation is reviewed.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.